Drugs / Resolvine
last change Oct 2015 re-read 3 minutes ago

Resolvine

Developed for
vitreous detachment
Investigated by
Jeffrey S Heier · Kato Pharmaceuticals, Inc.

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01966328 Oct 2013 → Oct 2015 vitreous detachment Jeffrey S Heier Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Resolvine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01966328 ↗
Route Intravitreal “intravitreal injection of Resolvine® 36%” NCT01966328 ↗